PANACCESS INNOVATIONS

Biological and Biotechnological Products, namely enzymes, nucleic acids, and biochemical and molecular biology reagents and consumables for research, diagnostics, and industrial applications; Biomolecules and biomanufactured products, namely, biochemicals and biofuels for scientific, medical, veterinary, and agricultural use; Synthetic biology tools and genetically engineered materials, namely, engineered enzymes, microbial strains, and nucleic acid constructs for biotechnology, pharmaceutical development, and biomanufacturing; Diagnostics and Analytical Technologies, namely, in vitro diagnostic (IVD) kits for medical, food safety, veterinary, and agricultural use; Lateral flow assays, nucleic acid-based amplification tests, and point-of-care diagnostic tests; Biomanufacturing and Bio-Based Materials, namely, fermentation-based, cell-free, and bioprocessed products, comprising microbial-derived enzymes, bioactive metabolites, synthetic peptides, recombinant proteins, and nucleic acid-based products; Bioengineered proteins, peptides, and functional biomaterials, namely, recombinant enzymes, synthetic peptides, antibodies, and protein-based biomaterials for pharmaceutical, regenerative medicine, and industrial applications; Sustainable and bio-derived materials, namely, bioplastics, biodegradable polymers, bio-based adhesives, and engineered biomaterials for industrial and commercial applications

AI-powered diagnostic platforms and biosensor technologies, namely, software for diagnostic data analysis, biosensor signal processing, and health monitoring; Software and Digital Solutions, namely, software for AI-driven diagnostics, laboratory automation, and data analysis; Software for data access, transfer and integration for diagnostic test interoperability, regulatory compliance, and secure data exchange; Digital platforms for remote diagnostics, decentralized testing, and clinical decision support

Software and Digital Solutions, Software as a services (SaaS) featuring software for AI-driven diagnostics, laboratory automation, and data analysis; Cloud-based Platform as a Services (PaaS) featuring bioinformatics platforms for genomic analysis, biomarker identification, and diagnostic data processing; Non-downloadable digital platforms for remote diagnostics, decentralized testing, and clinical decision support; Non-downloadable AI-powered diagnostic platforms and biosensor technologies, namely, software for diagnostic data analysis, biosensor signal processing, and health monitoring